Russia plans to produce 88 mln double doses of coronavirus vaccines in the first six months of the year, not including the CoviVac vaccine, Deputy Prime Minister Tatyana Golikova said on Saturday.
"We expect that 88 million double doses of coronavirus vaccines will be produced by the end of the first half of the year, not including CoviVac," she said, adding that 83 mln double doses of the Sputnik V vaccine would be manufactured, as well as 5.4 mln double doses of EpiVacCorona.
According to Golikova, 30.5 mln double doses of the vaccines will be produced in the first quarter of the year. She also said that 11.1 double doses of the vaccines have been manufactured in the country so far and 7.9 mln doses have been released for civil distribution, TASS reports.
On August 11, 2020, Russia became the first country to register a coronavirus vaccine, which was named Sputnik V. The vaccine was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology.
On February 20, Russian Prime Minister Mikhail Mishustin announced the registration of Russia's third coronavirus vaccine, the Chumakov Center's CoviVac, which is based on a whole inactivated virus.